EHA 2017 | Biosimilars in oncology: EHA 2017 session on rituximab

Bertrand Coiffier

Bertrand Coiffier, MD from the Centre Hospitalier Lyon-Sud, Pierre-Bénite, France discusses the session on the biosimilar rituximab held at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain. Prof. Coiffier explains some of the key topics discussed during the session, including the advantages of using biosimilars in practice, the rationale for their development biosimilars and the clinical evidence to date.

Share this video  
Similar topics
22nd June 2017